Aspergillusvaccines: Hardly worth studying or worthy of hard study?: Table 1.
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aspergillusvaccines: Hardly worth studying or worthy of hard study?: Table 1.
Authors
Keywords
-
Journal
MEDICAL MYCOLOGY
Volume 55, Issue 1, Pages 103-108
Publisher
Oxford University Press (OUP)
Online
2016-09-18
DOI
10.1093/mmy/myw081
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Calnexin Induces Expansion of Antigen-Specific CD4+ T Cells that Confer Immunity to Fungal Ascomycetes via Conserved Epitopes
- (2015) Marcel Wüthrich et al. Cell Host & Microbe
- Azole Resistance inAspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?
- (2015) Paul E. Verweij et al. CLINICAL INFECTIOUS DISEASES
- Application of the 2008 Definitions for Invasive Fungal Diseases to the Trial Comparing Voriconazole Versus Amphotericin B for Therapy of Invasive Aspergillosis: A Collaborative Study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases Group
- (2014) Raoul Herbrecht et al. CLINICAL INFECTIOUS DISEASES
- Identification of Immunogenic Antigens fromAspergillus fumigatusby Direct Multiparameter Characterization of Specific Conventional and Regulatory CD4+T Cells
- (2014) Petra Bacher et al. JOURNAL OF IMMUNOLOGY
- Multispecific Aspergillus T Cells Selected by CD137 or CD154 Induce Protective Immune Responses Against the Most Relevant Mold Infections
- (2014) Claudia Stuehler et al. JOURNAL OF INFECTIOUS DISEASES
- Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection
- (2014) P. R. Kumaresan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- mTOR- and HIF-1 -mediated aerobic glycolysis as metabolic basis for trained immunity
- (2014) S.-C. Cheng et al. SCIENCE
- Exploiting fungal cell wall components in vaccines
- (2014) Stuart M. Levitz et al. Seminars in Immunopathology
- Immunotherapy in Invasive Fungal Infection - Focus on Invasive Aspergillosis
- (2013) Thomas Lehrnbecher et al. CURRENT PHARMACEUTICAL DESIGN
- Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients
- (2013) Leonardo Potenza et al. PLoS One
- Beyond Empiricism: Informing Vaccine Development through Innate Immunity Research
- (2012) Stuart M. Levitz et al. CELL
- Adoptive immunity mediated by HLA-A*0201 restricted Asp f16 peptides-specific CD8+ T cells against Aspergillus fumigatus infection
- (2012) Z. Sun et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Fungi and allergic lower respiratory tract diseases
- (2012) Alan P. Knutsen et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Vaccination with mannan protects mice against systemic aspergillosis
- (2012) Min Liu et al. MEDICAL MYCOLOGY
- Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults
- (2012) David W. Denning et al. MEDICAL MYCOLOGY
- Hidden Killers: Human Fungal Infections
- (2012) G. D. Brown et al. Science Translational Medicine
- Developing a vaccine against aspergillosis
- (2010) David A. Stevens et al. MEDICAL MYCOLOGY
- Immune Sensing of Aspergillus fumigatus Proteins, Glycolipids, and Polysaccharides and the Impact on Th Immunity and Vaccination
- (2009) S. Bozza et al. JOURNAL OF IMMUNOLOGY
- A monoclonal IgM directed against immunodominant catalase B of cell wall ofAspergillus fumigatusexerts anti-A. fumigatusactivities
- (2009) Ashok K. Chaturvedi et al. MYCOSES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started